Probe set for isothermal one-pot reaction for detecting strains with biologically active biosynthetic pathway and uses thereof
US-2024376553-A1 · Nov 14, 2024 · US
US12473591B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12473591-B2 |
| Application number | US-202217687490-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2022 |
| Priority date | Jun 7, 2019 |
| Publication date | Nov 18, 2025 |
| Grant date | Nov 18, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a method for simultaneously detecting a plurality of pathogens from biologically-derived samples, and a kit for carrying out the method. Specifically, the present invention relates to a method for simultaneously detecting a plurality of pathogens that cause infectious uveitis, one of eye infections from samples such as anterior chamber fluid or vitreous by polymerase chain reaction (PCR), and a kit for carrying out the method.
Opening claim text (preview).
The invention claimed is: 1 . A method for detecting microorganisms in a sample, comprising (1) a step of mixing the sample with a PCR buffer comprising a nonionic surfactant; Tris buffer, containing KCl and MgCl 2 ; and a dNTP mix of dATP, dGTP, dCTP and dTTP to obtain a mixed solution; (2) a step of adding the mixed solution in step (1) to a plurality of tubes wherein each tube of the plurality of tubes comprises a solid composition for PCR reaction comprising a DNA polymerase and two types of PCR primer pairs which are selected from the group consisting of: (i) a Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene detection primer pair having the sequences of SEQ ID NO:1 and 2 and a TATA-binding protein (TBP) gene detection primer pair having the sequences of SEQ ID NO:3 and 4, (ii) a HSV-1 detection primer pair having the sequences of SEQ ID NO: 5 and 6 and a VZV detection primer pair having the sequences of SEQ ID NO: 7 and 8, (iii) a HSV-2 detection primer pair having the sequences of SEQ ID NO: 9 and 10 and a HHV-6 detection primer pair having the sequences of SEQ ID NO: 11 and 12, (iv) a EBV detection primer pair having the sequences of SEQ ID NO: 13 and 14 and a CMV detection primer pair having the sequences of SEQ ID NO: 15 and 16, and (v) a HTLV-1 detection primer pair having the sequences of SEQ ID NO: 17 and 18 and a Treponema pallidum detection primer pair having the sequences of SEQ ID NO: 19 and 20 and a toxoplasma detection primer pair having the sequences of SEQ ID NO:21 and 22; and (3) a step of detecting the PCR product generated in each of the plurality of tubes; wherein the sample is anterior chamber fluid or vitreous. 2 . The method according to claim 1 , wherein the amount of the sample is 12-20 μL. 3 . The method according to claim 1 , wherein the microorganism is selected from the group consisting of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), varicella zoster virus (VZV), Epstein-Barr virus (EBV), human herpesvirus type 6 (HHV-6), cytomegalovirus (CMV), human adult T-cell leukemia virus (HTLV-1), Treponema pallidum and toxoplasma. 4 . The method according to claim 1 , wherein in the step (2), the plurality of tubes comprises 2-12 tube strips. 5 . The method according to claim 1 , wherein in the step (2), the solid composition for PCR reaction contains an oligonucleotide probe labeled with one or more types of fluorescent dyes for fluorescent detection of PCR amplification products. 6 . The method according to claim 5 , wherein the fluorescent dyes are selected from the group consisting of FAM (6-carboxyfluorescein), ROX (6-carboxy-X-rhodamine), Cy5 (Cyanine dye) and HEX (4,7,2′,4′,5′,7′-hexachlorofluor-6-carboxyfluorescein). 7 . The method according to claim 1 , wherein in the step (2), the solid composition for PCR reaction is in a lyophilized form. 8 . The method according to claim 1 , wherein in the step (3), the PCR products are detected by real-time determination.
for protozoa · CPC title
characterised by the detection means (C12Q1/6804 takes precedence) · CPC title
involving dehydrogenase · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.